1. Home
  2. HCI vs VIR Comparison

HCI vs VIR Comparison

Compare HCI & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCI Group Inc.

HCI

HCI Group Inc.

HOLD

Current Price

$186.10

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.78

Market Cap

773.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCI
VIR
Founded
2006
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
773.5M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
HCI
VIR
Price
$186.10
$6.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$230.00
$25.73
AVG Volume (30 Days)
169.6K
1.8M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
0.85%
N/A
EPS Growth
32.29
N/A
EPS
15.80
N/A
Revenue
$816,578,000.00
$16,860,000.00
Revenue This Year
$19.65
N/A
Revenue Next Year
$9.97
$48.05
P/E Ratio
$11.86
N/A
Revenue Growth
8.75
N/A
52 Week Low
$106.89
$4.16
52 Week High
$210.50
$14.45

Technical Indicators

Market Signals
Indicator
HCI
VIR
Relative Strength Index (RSI) 57.44 61.51
Support Level $171.99 $6.49
Resistance Level $181.51 $6.89
Average True Range (ATR) 5.23 0.47
MACD 1.54 0.06
Stochastic Oscillator 97.12 83.17

Price Performance

Historical Comparison
HCI
VIR

About HCI HCI Group Inc.

HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: